NCT03356184View on ClinicalTrials.gov

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

May 15, 2018

Study Completion Date

May 15, 2018

Conditions
Vital Sign Monitoring
Interventions
DEVICE

The Rhea Vital Sign Vigilance Device Group

The RHEA device and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

DEVICE

The Earlysense System Device Group

The reference device Earlysense 2.0 system(vital sign monitoring system) and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

Trial Locations (1)

23298-0102

Virginia Commonwealth University School of Medicine, Richmond

All Listed Sponsors
collaborator

Virginia Commonwealth University

OTHER

lead

Darma Inc.

INDUSTRY

NCT03356184 - Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients | Biotech Hunter | Biotech Hunter